| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Receptor Substrate Proteins | 91 | 2023 | 553 | 7.200 |
Why?
|
| Insulin | 73 | 2023 | 6578 | 4.100 |
Why?
|
| Phosphoproteins | 51 | 2010 | 2433 | 3.120 |
Why?
|
| Insulin Resistance | 51 | 2023 | 3941 | 2.890 |
Why?
|
| Receptor, Insulin | 27 | 2023 | 833 | 2.430 |
Why?
|
| Liver | 29 | 2023 | 7502 | 1.840 |
Why?
|
| Forkhead Transcription Factors | 16 | 2018 | 1611 | 1.730 |
Why?
|
| Signal Transduction | 74 | 2021 | 23342 | 1.460 |
Why?
|
| Serine | 12 | 2019 | 828 | 1.440 |
Why?
|
| Glucose | 24 | 2023 | 4336 | 1.280 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 37 | 2021 | 2872 | 1.220 |
Why?
|
| Islets of Langerhans | 16 | 2019 | 1345 | 1.180 |
Why?
|
| Insulin-Secreting Cells | 11 | 2021 | 896 | 1.120 |
Why?
|
| Homeostasis | 18 | 2023 | 3301 | 1.050 |
Why?
|
| Follistatin | 3 | 2023 | 137 | 0.960 |
Why?
|
| Proto-Oncogene Proteins c-akt | 21 | 2020 | 2443 | 0.860 |
Why?
|
| Longevity | 6 | 2015 | 1050 | 0.850 |
Why?
|
| Mice, Knockout | 51 | 2023 | 14354 | 0.770 |
Why?
|
| Mice | 94 | 2023 | 81101 | 0.650 |
Why?
|
| Phosphorylation | 39 | 2022 | 8297 | 0.630 |
Why?
|
| Animals | 118 | 2023 | 167768 | 0.620 |
Why?
|
| Hyperglycemia | 7 | 2018 | 1368 | 0.610 |
Why?
|
| Cold Temperature | 1 | 2021 | 780 | 0.570 |
Why?
|
| Glucose Intolerance | 9 | 2021 | 575 | 0.560 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2016 | 203 | 0.530 |
Why?
|
| Threonine | 3 | 2014 | 270 | 0.530 |
Why?
|
| Glucagon-Secreting Cells | 2 | 2021 | 42 | 0.530 |
Why?
|
| Adaptation, Physiological | 3 | 2021 | 1295 | 0.520 |
Why?
|
| Food | 3 | 2009 | 771 | 0.500 |
Why?
|
| Mitochondria | 5 | 2014 | 3584 | 0.500 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 867 | 0.490 |
Why?
|
| Tyrosine | 7 | 2022 | 1432 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 2 | 17 | 2021 | 12075 | 0.470 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2022 | 597 | 0.450 |
Why?
|
| Diabetes Mellitus, Experimental | 6 | 2013 | 1111 | 0.450 |
Why?
|
| Gluconeogenesis | 5 | 2021 | 185 | 0.430 |
Why?
|
| Insulin-Like Growth Factor I | 7 | 2018 | 1927 | 0.430 |
Why?
|
| Hepatocytes | 7 | 2021 | 1230 | 0.400 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2004 | 1245 | 0.370 |
Why?
|
| Receptors, Leptin | 2 | 2012 | 350 | 0.370 |
Why?
|
| Mice, Transgenic | 16 | 2019 | 9518 | 0.360 |
Why?
|
| Blood Glucose | 16 | 2023 | 6346 | 0.350 |
Why?
|
| Lipid Metabolism | 4 | 2022 | 1895 | 0.350 |
Why?
|
| Glucagon | 5 | 2021 | 532 | 0.330 |
Why?
|
| Phosphatidylinositol 3-Kinases | 18 | 2016 | 2858 | 0.320 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 185 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 1477 | 0.320 |
Why?
|
| CHO Cells | 5 | 2016 | 1389 | 0.320 |
Why?
|
| Enzyme Activation | 7 | 2013 | 3593 | 0.320 |
Why?
|
| Muscle, Skeletal | 11 | 2021 | 4902 | 0.320 |
Why?
|
| Hyperinsulinism | 7 | 2020 | 400 | 0.320 |
Why?
|
| Hypoglycemic Agents | 7 | 2014 | 3069 | 0.310 |
Why?
|
| Growth | 2 | 2008 | 365 | 0.310 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2021 | 295 | 0.310 |
Why?
|
| Endocrine Glands | 1 | 2008 | 101 | 0.310 |
Why?
|
| Metabolic Diseases | 3 | 2012 | 682 | 0.310 |
Why?
|
| Cricetinae | 5 | 2016 | 2426 | 0.300 |
Why?
|
| Protein Kinase C | 6 | 2013 | 1199 | 0.300 |
Why?
|
| Cricetulus | 4 | 2016 | 815 | 0.290 |
Why?
|
| TOR Serine-Threonine Kinases | 8 | 2016 | 2057 | 0.290 |
Why?
|
| Obesity | 11 | 2023 | 12870 | 0.290 |
Why?
|
| Leptin | 4 | 2012 | 1591 | 0.280 |
Why?
|
| Diabetes Mellitus | 7 | 2007 | 5816 | 0.280 |
Why?
|
| Multiprotein Complexes | 4 | 2018 | 1120 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2021 | 2895 | 0.270 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 1710 | 0.270 |
Why?
|
| Gene Deletion | 4 | 2021 | 2666 | 0.260 |
Why?
|
| Central Nervous System | 1 | 2012 | 1333 | 0.250 |
Why?
|
| Trans-Activators | 6 | 2009 | 2860 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2010 | 3432 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 21 | 2022 | 22003 | 0.250 |
Why?
|
| Enzyme Inhibitors | 8 | 2022 | 3709 | 0.250 |
Why?
|
| Body Weight | 7 | 2021 | 4603 | 0.250 |
Why?
|
| Adipocytes | 3 | 2009 | 1177 | 0.240 |
Why?
|
| Huntington Disease | 1 | 2011 | 1141 | 0.240 |
Why?
|
| Photoreceptor Cells | 1 | 2005 | 236 | 0.230 |
Why?
|
| Down-Regulation | 5 | 2022 | 2904 | 0.230 |
Why?
|
| Protein Kinases | 3 | 2006 | 1610 | 0.220 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2018 | 686 | 0.220 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2008 | 1113 | 0.220 |
Why?
|
| Neurons | 4 | 2020 | 9416 | 0.220 |
Why?
|
| Organ Specificity | 3 | 2021 | 1955 | 0.220 |
Why?
|
| Cyclin D1 | 1 | 2005 | 451 | 0.210 |
Why?
|
| Amino Acid Substitution | 3 | 2016 | 1734 | 0.210 |
Why?
|
| Gene Expression Regulation | 9 | 2021 | 11892 | 0.210 |
Why?
|
| Cyclins | 1 | 2005 | 593 | 0.210 |
Why?
|
| Up-Regulation | 4 | 2012 | 4113 | 0.210 |
Why?
|
| Pyrazolones | 1 | 2022 | 8 | 0.200 |
Why?
|
| Metformin | 2 | 2012 | 907 | 0.200 |
Why?
|
| Glycogen Synthase Kinase 3 | 4 | 2010 | 408 | 0.200 |
Why?
|
| Nitrobenzenes | 1 | 2022 | 66 | 0.200 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2018 | 1486 | 0.200 |
Why?
|
| Basal Metabolism | 1 | 2023 | 161 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2016 | 2800 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 459 | 0.190 |
Why?
|
| Apoptosis | 12 | 2013 | 9468 | 0.190 |
Why?
|
| Eye Proteins | 1 | 2005 | 633 | 0.190 |
Why?
|
| Brain | 7 | 2021 | 26947 | 0.190 |
Why?
|
| Crosses, Genetic | 4 | 2009 | 751 | 0.190 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2022 | 150 | 0.180 |
Why?
|
| Anisomycin | 3 | 2014 | 27 | 0.180 |
Why?
|
| Gene Expression | 7 | 2018 | 7583 | 0.180 |
Why?
|
| Life Expectancy | 1 | 2008 | 1244 | 0.180 |
Why?
|
| Adipose Tissue | 6 | 2021 | 3299 | 0.180 |
Why?
|
| Adipokines | 1 | 2023 | 311 | 0.180 |
Why?
|
| rho-Associated Kinases | 3 | 2018 | 280 | 0.180 |
Why?
|
| Feedback, Physiological | 2 | 2021 | 475 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 3 | 2012 | 4406 | 0.180 |
Why?
|
| Benzoates | 1 | 2022 | 211 | 0.180 |
Why?
|
| Organ Size | 5 | 2010 | 2252 | 0.170 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 149 | 0.170 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2020 | 114 | 0.170 |
Why?
|
| Cell Differentiation | 4 | 2018 | 11471 | 0.170 |
Why?
|
| Mice, Mutant Strains | 5 | 2011 | 1751 | 0.170 |
Why?
|
| Obesity, Abdominal | 1 | 2023 | 374 | 0.170 |
Why?
|
| Oxidation-Reduction | 2 | 2021 | 2221 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 1725 | 0.160 |
Why?
|
| Homeodomain Proteins | 3 | 2005 | 2413 | 0.160 |
Why?
|
| Overnutrition | 1 | 2018 | 25 | 0.160 |
Why?
|
| Blotting, Western | 7 | 2014 | 5031 | 0.160 |
Why?
|
| Energy Metabolism | 5 | 2021 | 2868 | 0.150 |
Why?
|
| Rats | 13 | 2016 | 23679 | 0.150 |
Why?
|
| 3T3-L1 Cells | 1 | 2018 | 209 | 0.150 |
Why?
|
| Cell Line | 13 | 2014 | 15591 | 0.150 |
Why?
|
| Ubiquitin | 1 | 2002 | 837 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2016 | 1245 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 2 | 2010 | 363 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1610 | 0.140 |
Why?
|
| Prediabetic State | 1 | 2023 | 547 | 0.140 |
Why?
|
| Receptor, IGF Type 1 | 5 | 2013 | 380 | 0.140 |
Why?
|
| Lipogenesis | 1 | 2018 | 210 | 0.140 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2017 | 122 | 0.140 |
Why?
|
| Postprandial Period | 1 | 2018 | 314 | 0.140 |
Why?
|
| Tuberous Sclerosis | 1 | 2004 | 1030 | 0.140 |
Why?
|
| Thermogenesis | 1 | 2021 | 468 | 0.140 |
Why?
|
| Adipose Tissue, Brown | 2 | 2021 | 755 | 0.130 |
Why?
|
| Cell Dedifferentiation | 1 | 2016 | 122 | 0.130 |
Why?
|
| Endotoxemia | 1 | 2017 | 196 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2016 | 126 | 0.130 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 503 | 0.130 |
Why?
|
| Cells, Cultured | 12 | 2016 | 18940 | 0.130 |
Why?
|
| NAD | 2 | 2010 | 609 | 0.130 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 18119 | 0.130 |
Why?
|
| Genes, ras | 1 | 2018 | 654 | 0.120 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 365 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2021 | 1573 | 0.120 |
Why?
|
| Mice, Obese | 3 | 2023 | 420 | 0.120 |
Why?
|
| Humans | 52 | 2023 | 758406 | 0.120 |
Why?
|
| Transcription Factors | 9 | 2023 | 12094 | 0.120 |
Why?
|
| Immunoprecipitation | 5 | 2011 | 877 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 483 | 0.120 |
Why?
|
| Thapsigargin | 1 | 2014 | 102 | 0.120 |
Why?
|
| Cell Survival | 4 | 2005 | 5781 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 3 | 2004 | 74 | 0.120 |
Why?
|
| Tunicamycin | 1 | 2014 | 108 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 100 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 4901 | 0.110 |
Why?
|
| Interleukin-4 | 3 | 2002 | 1130 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2013 | 29 | 0.110 |
Why?
|
| Carrier Proteins | 3 | 2004 | 4938 | 0.110 |
Why?
|
| Peptides | 1 | 2005 | 4341 | 0.110 |
Why?
|
| Glucose Tolerance Test | 5 | 2013 | 1172 | 0.110 |
Why?
|
| Cell Division | 5 | 2003 | 4458 | 0.110 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2005 | 441 | 0.110 |
Why?
|
| Models, Biological | 5 | 2010 | 9460 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2021 | 2772 | 0.110 |
Why?
|
| Animals, Newborn | 5 | 2007 | 2672 | 0.110 |
Why?
|
| Male | 41 | 2021 | 358747 | 0.110 |
Why?
|
| Thiolester Hydrolases | 1 | 2013 | 85 | 0.110 |
Why?
|
| Somatomedins | 2 | 2003 | 178 | 0.100 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2013 | 88 | 0.100 |
Why?
|
| tau Proteins | 1 | 2003 | 2085 | 0.100 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 1256 | 0.100 |
Why?
|
| Immunoblotting | 4 | 2017 | 1647 | 0.100 |
Why?
|
| Receptor, trkA | 1 | 2013 | 159 | 0.100 |
Why?
|
| Dietary Fats | 4 | 2010 | 1991 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2013 | 143 | 0.100 |
Why?
|
| Nerve Growth Factor | 1 | 2013 | 158 | 0.100 |
Why?
|
| Proteins | 3 | 2004 | 6026 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2002 | 2980 | 0.100 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 76 | 0.100 |
Why?
|
| Urinary Bladder Diseases | 1 | 2012 | 169 | 0.100 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 256 | 0.090 |
Why?
|
| Glycogen Synthase | 3 | 2009 | 61 | 0.090 |
Why?
|
| Kidney Tubules | 1 | 2013 | 449 | 0.090 |
Why?
|
| Membrane Proteins | 5 | 2017 | 7843 | 0.090 |
Why?
|
| Heart | 2 | 2014 | 4382 | 0.090 |
Why?
|
| Cell Proliferation | 6 | 2013 | 10416 | 0.090 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2012 | 114 | 0.090 |
Why?
|
| Cyclic AMP | 2 | 2005 | 1455 | 0.090 |
Why?
|
| Amino Acids | 4 | 2018 | 1713 | 0.090 |
Why?
|
| Liver Glycogen | 1 | 2009 | 35 | 0.090 |
Why?
|
| Angiotensin II | 1 | 2013 | 848 | 0.090 |
Why?
|
| Pancreas | 3 | 2005 | 1676 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2009 | 695 | 0.090 |
Why?
|
| Hippocampus | 2 | 2021 | 3736 | 0.090 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2009 | 37 | 0.090 |
Why?
|
| Long-Term Potentiation | 1 | 2011 | 293 | 0.090 |
Why?
|
| Autophagy | 2 | 2018 | 1322 | 0.090 |
Why?
|
| Endothelial Cells | 2 | 2013 | 3533 | 0.080 |
Why?
|
| Electron Transport | 1 | 2010 | 206 | 0.080 |
Why?
|
| Transfection | 7 | 2010 | 5779 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2016 | 1317 | 0.080 |
Why?
|
| Clozapine | 1 | 2013 | 506 | 0.080 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 246 | 0.080 |
Why?
|
| Diphtheria Toxin | 1 | 2010 | 252 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4429 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 293 | 0.080 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 419 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2009 | 268 | 0.080 |
Why?
|
| RNA, Messenger | 6 | 2010 | 12759 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 2912 | 0.080 |
Why?
|
| Bariatric Surgery | 1 | 2018 | 986 | 0.080 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2007 | 53 | 0.070 |
Why?
|
| Epidermis | 2 | 2007 | 528 | 0.070 |
Why?
|
| Phosphotyrosine | 4 | 2013 | 455 | 0.070 |
Why?
|
| Cell Death | 2 | 2010 | 1668 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2004 | 31 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2564 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 13447 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 4342 | 0.070 |
Why?
|
| Mitosis | 2 | 2009 | 1191 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 1342 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 655 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 892 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 1972 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 855 | 0.070 |
Why?
|
| Diabetic Nephropathies | 1 | 2013 | 973 | 0.070 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 13245 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 2 | 2009 | 474 | 0.060 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 124 | 0.060 |
Why?
|
| Receptors, Glucagon | 1 | 2005 | 90 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 17617 | 0.060 |
Why?
|
| Venoms | 1 | 2005 | 95 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2010 | 1133 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2005 | 4485 | 0.060 |
Why?
|
| Mutation | 7 | 2016 | 29915 | 0.060 |
Why?
|
| Cyclin D2 | 1 | 2005 | 98 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2011 | 1169 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4567 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 611 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 1825 | 0.060 |
Why?
|
| Aging | 3 | 2011 | 8650 | 0.060 |
Why?
|
| Stress, Physiological | 2 | 2009 | 1398 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 1655 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 593 | 0.060 |
Why?
|
| Female | 26 | 2021 | 390323 | 0.060 |
Why?
|
| Guinea Pigs | 1 | 2005 | 1317 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 148 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 10748 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2004 | 95 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 610 | 0.060 |
Why?
|
| Burns | 2 | 2005 | 1848 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2014 | 3997 | 0.050 |
Why?
|
| Bipolar Disorder | 1 | 2020 | 5079 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 311 | 0.050 |
Why?
|
| Integrases | 1 | 2005 | 516 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 1986 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2012 | 1268 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1743 | 0.050 |
Why?
|
| Fasting | 1 | 2009 | 1599 | 0.050 |
Why?
|
| Apolipoproteins E | 2 | 2007 | 1436 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 814 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2005 | 459 | 0.050 |
Why?
|
| Ceruloplasmin | 1 | 2022 | 56 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1136 | 0.050 |
Why?
|
| Propidium | 1 | 2002 | 42 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 2129 | 0.050 |
Why?
|
| Cell Line, Tumor | 7 | 2017 | 16886 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 609 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2002 | 365 | 0.050 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2005 | 738 | 0.050 |
Why?
|
| Alanine | 2 | 2019 | 603 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 460 | 0.050 |
Why?
|
| Androstadienes | 1 | 2003 | 348 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2020 | 6910 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2004 | 507 | 0.050 |
Why?
|
| Interleukin-9 | 1 | 2002 | 61 | 0.050 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2002 | 173 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 623 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 802 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 6520 | 0.050 |
Why?
|
| Body Composition | 1 | 2010 | 2416 | 0.050 |
Why?
|
| Heterozygote | 2 | 2009 | 2797 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 522 | 0.050 |
Why?
|
| Regeneration | 1 | 2010 | 1505 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2010 | 2533 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 1845 | 0.050 |
Why?
|
| Rabbits | 1 | 2007 | 4772 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 490 | 0.050 |
Why?
|
| Respiration | 1 | 2007 | 1654 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 458 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2011 | 3099 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1693 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 562 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 6313 | 0.040 |
Why?
|
| Copper | 1 | 2022 | 366 | 0.040 |
Why?
|
| Random Allocation | 1 | 2004 | 2385 | 0.040 |
Why?
|
| Binding Sites | 2 | 2013 | 6036 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2007 | 1138 | 0.040 |
Why?
|
| Cell Cycle Proteins | 3 | 2010 | 3442 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2020 | 68 | 0.040 |
Why?
|
| Sirolimus | 2 | 2004 | 1533 | 0.040 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2002 | 314 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2020 | 174 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5246 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 2021 | 286 | 0.040 |
Why?
|
| Cell Count | 1 | 2003 | 1835 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1404 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2004 | 998 | 0.040 |
Why?
|
| DNA | 2 | 2010 | 7199 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4284 | 0.040 |
Why?
|
| Kinetics | 2 | 2004 | 6371 | 0.040 |
Why?
|
| Time Factors | 6 | 2007 | 39872 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2006 | 4087 | 0.040 |
Why?
|
| Glycogen | 2 | 2014 | 251 | 0.040 |
Why?
|
| Kidney | 3 | 2010 | 7016 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2005 | 806 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2008 | 11070 | 0.040 |
Why?
|
| Lipids | 3 | 2022 | 3326 | 0.040 |
Why?
|
| Photic Stimulation | 1 | 2005 | 1967 | 0.040 |
Why?
|
| Point Mutation | 1 | 2003 | 1593 | 0.040 |
Why?
|
| Diet | 2 | 2007 | 8005 | 0.040 |
Why?
|
| Myocardium | 1 | 2010 | 4690 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 3480 | 0.040 |
Why?
|
| Cytokines | 2 | 2003 | 7338 | 0.040 |
Why?
|
| Codon, Terminator | 1 | 2018 | 125 | 0.040 |
Why?
|
| Eating | 1 | 2004 | 1536 | 0.040 |
Why?
|
| Genotype | 3 | 2009 | 12945 | 0.040 |
Why?
|
| Atherosclerosis | 2 | 2018 | 3401 | 0.040 |
Why?
|
| Models, Animal | 1 | 2004 | 2112 | 0.040 |
Why?
|
| Age Factors | 2 | 2005 | 18358 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2020 | 591 | 0.040 |
Why?
|
| Disease Progression | 2 | 2011 | 13468 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2009 | 3184 | 0.040 |
Why?
|
| Protein Stability | 1 | 2018 | 566 | 0.030 |
Why?
|
| Cattle | 2 | 2013 | 3845 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2016 | 8143 | 0.030 |
Why?
|
| Glucose Clamp Technique | 2 | 2008 | 263 | 0.030 |
Why?
|
| Granulosa Cells | 1 | 2016 | 115 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3432 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 367 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 5 | 2007 | 5779 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2013 | 929 | 0.030 |
Why?
|
| Overweight | 1 | 2007 | 2411 | 0.030 |
Why?
|
| Cerebellum | 1 | 2003 | 1497 | 0.030 |
Why?
|
| Smoking | 1 | 2012 | 9051 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 2567 | 0.030 |
Why?
|
| Diabetic Retinopathy | 1 | 2005 | 1267 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 2016 | 243 | 0.030 |
Why?
|
| Ovarian Follicle | 1 | 2016 | 244 | 0.030 |
Why?
|
| Adiponectin | 2 | 2014 | 1114 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2014 | 1694 | 0.030 |
Why?
|
| Protein Binding | 4 | 2013 | 9311 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1803 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2013 | 1134 | 0.030 |
Why?
|
| Muscle Contraction | 2 | 2012 | 1197 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 9574 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2009 | 4641 | 0.030 |
Why?
|
| Rats, Zucker | 1 | 2013 | 131 | 0.030 |
Why?
|
| Swimming | 1 | 2014 | 206 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2013 | 66 | 0.030 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2013 | 37 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 110 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 1759 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2013 | 317 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3733 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 91 | 0.030 |
Why?
|
| Deoxyglucose | 2 | 2005 | 333 | 0.030 |
Why?
|
| Bone Density | 1 | 2005 | 3533 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2005 | 319 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 462 | 0.030 |
Why?
|
| Heart Failure | 2 | 2013 | 11593 | 0.030 |
Why?
|
| Base Sequence | 3 | 2013 | 12436 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2013 | 229 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2012 | 121 | 0.030 |
Why?
|
| Keratinocytes | 2 | 2007 | 790 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2013 | 818 | 0.030 |
Why?
|
| Smad4 Protein | 1 | 2013 | 191 | 0.030 |
Why?
|
| Glucokinase | 1 | 2012 | 102 | 0.020 |
Why?
|
| Fetal Heart | 1 | 2013 | 281 | 0.020 |
Why?
|
| bcl-X Protein | 2 | 2004 | 411 | 0.020 |
Why?
|
| Motor Activity | 1 | 2002 | 2685 | 0.020 |
Why?
|
| STAT6 Transcription Factor | 2 | 2002 | 193 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 495 | 0.020 |
Why?
|
| Life Style | 1 | 2023 | 3886 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 1411 | 0.020 |
Why?
|
| Retroviridae | 2 | 2003 | 850 | 0.020 |
Why?
|
| Adenoviridae | 2 | 2005 | 1084 | 0.020 |
Why?
|
| Pyruvic Acid | 1 | 2010 | 195 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2011 | 664 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 2204 | 0.020 |
Why?
|
| Portal Vein | 1 | 2012 | 429 | 0.020 |
Why?
|
| Biological Transport | 2 | 2005 | 2084 | 0.020 |
Why?
|
| Survival Rate | 1 | 2003 | 12721 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2013 | 541 | 0.020 |
Why?
|
| Triglycerides | 2 | 2008 | 2451 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 931 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 4738 | 0.020 |
Why?
|
| DNA, Neoplasm | 2 | 2004 | 1745 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5892 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 703 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 1171 | 0.020 |
Why?
|
| Epithelium | 1 | 2013 | 1605 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3796 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 857 | 0.020 |
Why?
|
| Nicotine | 1 | 2012 | 677 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1335 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 818 | 0.020 |
Why?
|
| Italy | 1 | 2009 | 839 | 0.020 |
Why?
|
| Dogs | 1 | 2012 | 3840 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 1752 | 0.020 |
Why?
|
| Neoplasms | 2 | 2008 | 22032 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1507 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1262 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 660 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2012 | 1166 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 5349 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3609 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6493 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 2816 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2005 | 149 | 0.020 |
Why?
|
| Thymidine | 1 | 2005 | 299 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2005 | 2907 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 1900 | 0.020 |
Why?
|
| Membranes | 1 | 2004 | 165 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 2004 | 67 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 10171 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4257 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 10718 | 0.010 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2003 | 39 | 0.010 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2003 | 72 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2008 | 1792 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 989 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2003 | 140 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 2332 | 0.010 |
Why?
|
| Hindlimb | 1 | 2005 | 509 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2008 | 1974 | 0.010 |
Why?
|
| Phenotype | 2 | 2016 | 16534 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7403 | 0.010 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2002 | 61 | 0.010 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2003 | 202 | 0.010 |
Why?
|
| C-Peptide | 1 | 2004 | 433 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2003 | 257 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2004 | 553 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2009 | 3612 | 0.010 |
Why?
|
| Electroporation | 1 | 2004 | 254 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 640 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 3069 | 0.010 |
Why?
|
| Fetus | 1 | 2009 | 1859 | 0.010 |
Why?
|
| Diglycerides | 1 | 2002 | 176 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2004 | 330 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2005 | 837 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12604 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2557 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 869 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2002 | 101 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 695 | 0.010 |
Why?
|
| Growth Disorders | 1 | 2007 | 653 | 0.010 |
Why?
|
| Pregnancy | 3 | 2012 | 29742 | 0.010 |
Why?
|
| Middle Aged | 4 | 2021 | 219568 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2796 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9404 | 0.010 |
Why?
|
| Breast Neoplasms | 4 | 2016 | 21017 | 0.010 |
Why?
|
| Exocytosis | 1 | 2002 | 319 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 392 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 436 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 886 | 0.010 |
Why?
|
| Muscles | 1 | 2005 | 1579 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1055 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 1257 | 0.010 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2003 | 362 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1543 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 714 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2005 | 856 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6068 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 772 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 1788 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 7590 | 0.010 |
Why?
|
| Feedback | 1 | 2003 | 791 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1007 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2004 | 1173 | 0.010 |
Why?
|
| Endometrial Neoplasms | 1 | 2008 | 1357 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2003 | 1133 | 0.010 |
Why?
|
| Adiposity | 1 | 2009 | 1858 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1844 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 1203 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 1686 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 1527 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 2416 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2004 | 1150 | 0.010 |
Why?
|
| Alleles | 1 | 2009 | 6895 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 58683 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 2219 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 5410 | 0.010 |
Why?
|
| Aorta | 1 | 2005 | 2037 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2005 | 3991 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2275 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2002 | 1047 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 3617 | 0.010 |
Why?
|
| Cell Separation | 1 | 2002 | 1720 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 6127 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2825 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2646 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22029 | 0.010 |
Why?
|
| Young Adult | 2 | 2013 | 58808 | 0.010 |
Why?
|
| Child | 2 | 2013 | 79818 | 0.010 |
Why?
|
| Adult | 3 | 2016 | 219935 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2002 | 2610 | 0.010 |
Why?
|
| Biopsy | 1 | 2005 | 6768 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2003 | 2638 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 87892 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 5737 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 5864 | 0.010 |
Why?
|
| Skin | 1 | 2005 | 4464 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5098 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 3664 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 168218 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 12876 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2004 | 5629 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 8506 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11336 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 73809 | 0.000 |
Why?
|